Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -18.30 |
| peg ratio | -5.08 |
| price to book ratio | 5.42 |
| price to sales ratio | 3.85 |
| enterprise value multiple | -30.53 |
| price fair value | 5.42 |
profitability ratios | |
|---|---|
| gross profit margin | 35.86% |
| operating profit margin | -19.5% |
| pretax profit margin | -21.0% |
| net profit margin | -21.03% |
| return on assets | -15.6% |
| return on equity | -30.89% |
| return on capital employed | -23.85% |
liquidity ratio | |
|---|---|
| current ratio | 1.98 |
| quick ratio | 1.27 |
| cash ratio | 1.13 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 214.33 |
| operating cycle | 231.88 |
| days of payables outstanding | 39.07 |
| cash conversion cycle | 192.81 |
| receivables turnover | 20.81 |
| payables turnover | 9.34 |
| inventory turnover | 1.70 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | 0.18 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.15 |
| interest coverage | -4.77 |
| cash flow to debt ratio | 1.46 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.10 |
| cash per share | 0.37 |
| operating cash flow per share | 0.11 |
| free cash flow operating cash flow ratio | 0.87 |
| cash flow coverage ratios | 1.46 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 7.48 |
Frequently Asked Questions
Protalix BioTherapeutics, Inc. (PLX) published its most recent earnings results on 14-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Protalix BioTherapeutics, Inc. (AMEX:PLX)'s trailing twelve months ROE is -30.89%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Protalix BioTherapeutics, Inc. (PLX) currently has a ROA of -15.6%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PLX reported a profit margin of -21.03% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.98 in the most recent quarter. The quick ratio stood at 1.27, with a Debt/Eq ratio of 0.18.